A detailed history of Parcion Private Wealth LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Parcion Private Wealth LLC holds 5,024 shares of BMY stock, worth $295,762. This represents 0.02% of its overall portfolio holdings.

Number of Shares
5,024
Holding current value
$295,762
% of portfolio
0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$39.66 - $51.75 $199,251 - $259,992
5,024 New
5,024 $259,000
Q1 2024

Apr 24, 2024

SELL
$47.98 - $54.4 $8,588 - $9,737
-179 Reduced 3.13%
5,534 $300,000
Q1 2023

May 11, 2023

BUY
$65.71 - $74.53 $8,805 - $9,987
134 Added 2.4%
5,713 $395,000
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $18,881 - $20,794
260 Added 4.89%
5,579 $409,000
Q1 2022

May 06, 2022

SELL
$61.48 - $73.72 $16,046 - $19,240
-261 Reduced 4.68%
5,319 $408,000
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $53 - $62
1 Added 0.02%
5,580 $362,000
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $15,798 - $18,505
267 Added 5.03%
5,579 $326,000
Q1 2021

Apr 08, 2021

SELL
$59.34 - $66.74 $32,637 - $36,707
-550 Reduced 9.38%
5,312 $335,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $115,480 - $130,860
2,000 Added 51.79%
5,862 $364,000
Q3 2020

Oct 20, 2020

SELL
$57.43 - $63.64 $74,659 - $82,732
-1,300 Reduced 25.18%
3,862 $227,000
Q1 2020

Apr 29, 2020

SELL
$46.4 - $67.43 $17,492 - $25,421
-377 Reduced 6.81%
5,162 $288,000
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $272,574 - $355,548
5,539 New
5,539 $356,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Parcion Private Wealth LLC Portfolio

Follow Parcion Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parcion Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parcion Private Wealth LLC with notifications on news.